These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26112921)

  • 1. Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine-Dependent Arrest in the T-cell Signaling Cascade.
    Kelleher RJ; Balu-Iyer S; Loyall J; Sacca AJ; Shenoy GN; Peng P; Iyer V; Fathallah AM; Berenson CS; Wallace PK; Tario J; Odunsi K; Bankert RB
    Cancer Immunol Res; 2015 Nov; 3(11):1269-78. PubMed ID: 26112921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients.
    Landskron J; Helland Ø; Torgersen KM; Aandahl EM; Gjertsen BT; Bjørge L; Taskén K
    Cancer Immunol Immunother; 2015 Mar; 64(3):337-47. PubMed ID: 25416072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma.
    Czystowska-Kuzmicz M; Sosnowska A; Nowis D; Ramji K; Szajnik M; Chlebowska-Tuz J; Wolinska E; Gaj P; Grazul M; Pilch Z; Zerrouqi A; Graczyk-Jarzynka A; Soroczynska K; Cierniak S; Koktysz R; Elishaev E; Gruca S; Stefanowicz A; Blaszczyk R; Borek B; Gzik A; Whiteside T; Golab J
    Nat Commun; 2019 Jul; 10(1):3000. PubMed ID: 31278254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells.
    Simpson-Abelson MR; Loyall JL; Lehman HK; Barnas JL; Minderman H; O'Loughlin KL; Wallace PK; George TC; Peng P; Kelleher RJ; Odunsi K; Bankert RB
    Cancer Immun; 2013; 13():14. PubMed ID: 23882159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer.
    Webb JR; Wick DA; Nielsen JS; Tran E; Milne K; McMurtrie E; Nelson BH
    Gynecol Oncol; 2010 Sep; 118(3):228-36. PubMed ID: 20541243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments.
    Bhatta M; Shenoy GN; Loyall JL; Gray BD; Bapardekar M; Conway A; Minderman H; Kelleher RJ; Carreno BM; Linette G; Shultz LD; Odunsi K; Balu-Iyer SV; Pak KY; Bankert RB
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System.
    Wefers C; Duiveman-de Boer T; Zusterzeel PLM; Massuger LFAG; Fuchs D; Torensma R; Wheelock CE; de Vries IJM
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29342108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
    Giuntoli RL; Webb TJ; Zoso A; Rogers O; Diaz-Montes TP; Bristow RE; Oelke M
    Anticancer Res; 2009 Aug; 29(8):2875-84. PubMed ID: 19661290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes Represent an Immune Suppressive T Cell Checkpoint in Human Chronic Inflammatory Microenvironments.
    Shenoy GN; Bhatta M; Loyall JL; Kelleher RJ; Bernstein JM; Bankert RB
    Immunol Invest; 2020 Oct; 49(7):726-743. PubMed ID: 32299258
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
    Guo Z; Wang H; Meng F; Li J; Zhang S
    J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G; Gückel B; Wallwiener D; Moldenhauer G
    Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialic Acid-Dependent Inhibition of T Cells by Exosomal Ganglioside GD3 in Ovarian Tumor Microenvironments.
    Shenoy GN; Loyall J; Berenson CS; Kelleher RJ; Iyer V; Balu-Iyer SV; Odunsi K; Bankert RB
    J Immunol; 2018 Dec; 201(12):3750-3758. PubMed ID: 30446565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism.
    Yang T; Wall EM; Milne K; Theiss P; Watson P; Nelson BH
    Clin Cancer Res; 2007 Dec; 13(23):7172-80. PubMed ID: 18056198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human lymphoblastoid cell line proliferation by ascites fluids from ovarian cancer patients.
    Hess AD; Gall SA; Dawson JR
    Cancer Res; 1980 Dec; 40(12):4495-500. PubMed ID: 7438082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytes infiltrating ovarian malignant ascites: modulation of IL-2-induced proliferation by IL-4 and of selective increase in CD8+ T cells by TNF-alpha.
    Ioannides CG; Rashed S; Fisk B; Fan D; Itoh K; Freedman RS
    Lymphokine Cytokine Res; 1991 Aug; 10(4):307-15. PubMed ID: 1932375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
    Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
    Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
    Wei S; Kryczek I; Zou L; Daniel B; Cheng P; Mottram P; Curiel T; Lange A; Zou W
    Cancer Res; 2005 Jun; 65(12):5020-6. PubMed ID: 15958543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression.
    Bak SP; Alonso A; Turk MJ; Berwin B
    Mol Immunol; 2008 Dec; 46(2):258-68. PubMed ID: 18824264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells.
    Lindner S; Dahlke K; Sontheimer K; Hagn M; Kaltenmeier C; Barth TF; Beyer T; Reister F; Fabricius D; Lotfi R; Lunov O; Nienhaus GU; Simmet T; Kreienberg R; Möller P; Schrezenmeier H; Jahrsdörfer B
    Cancer Res; 2013 Apr; 73(8):2468-79. PubMed ID: 23384943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.